Final Primary Results from the Defifrance Registry Study: Effectiveness and Safety of Defibrotide in the Treatment of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Hematopoietic Cell Transplantation - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Blood Année : 2020

Final Primary Results from the Defifrance Registry Study: Effectiveness and Safety of Defibrotide in the Treatment of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Hematopoietic Cell Transplantation

(1) , (2, 3) , (1) , (4) , (5, 6) , (7, 8) , (9) , (10, 11) , (12) , (13) , (13) , (14, 15, 16) , (17)
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
Mohamad Mohty
Myriam Labopin
Sebastien Maury
  • Fonction : Auteur

Dates et versions

hal-03606392 , version 1 (11-03-2022)

Identifiants

Citer

Mohamad Mohty, Ibrahim Yakoub-Agha, Myriam Labopin, Didier Blaise, Delphine Lebon, et al.. Final Primary Results from the Defifrance Registry Study: Effectiveness and Safety of Defibrotide in the Treatment of Hepatic Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Hematopoietic Cell Transplantation. Blood, 2020, 136 (1), ⟨10.1182/blood-2020-136685⟩. ⟨hal-03606392⟩
10 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook Twitter LinkedIn More